In conclusion, to the best of our knowledge, the present study has reported for the first time on the association of YBX3 with ccRCC progression and prognosis in vitro through bioinformatics and cell biological function analyses. The gene discussed is YBX3; the disease is nonpapillary renal cell carcinoma.